Galmed Pharmaceuticals Ltd. (GLMD)
0.5701
+0.05
(+9.42%)
USD |
NASDAQ |
Apr 07, 16:00
0.577
+0.01
(+1.21%)
After-Hours: 20:00
Galmed Pharmaceuticals EPS Diluted (Quarterly) : -0.7321 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | 0.6002 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.32 |
| XTL Biopharmaceuticals Ltd. | -0.1169 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.818M |
| Total Expenses (Quarterly) | 4.818M |
| Enterprise Value | -14.52M |
| Earnings Yield | -369.2% |
| Normalized Earnings Yield | -321.80 |